Search Results
Results found for "Sosei Heptares"
Posts (48)
- California gold rush for Sosei Heptares
November 2021 "Cambridge’s Japanese-owned life sciences company Sosei Heptares has clinched a lucrative
- Verily links up with Sosei Heptares for GPCR drug discovery
Among those hitching their wagons to that star are Verily and Sosei Heptares, which have struck a research The financial details of the strategic collaboration weren’t released, but Sosei Heptares’ past two team-ups
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
December 2021 "Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“Sosei Heptares under the HSR Act, under the terms of the License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares an upfront payment of US$100 million, with the amount to be recognized as revenue in the fourth
Other Pages (4)
- Dr. Chris Tate | Dr. GPCR Ecosystem
Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Sosei and became Sosei Heptares . Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory
- Annabelle Milner | Dr. GPCR Ecosystem
Alastair Brown (Sosei Heptares), where she is currently a final year Ph.D. student.
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Chris Tate's thermostabilization strategy finally made GPCR structures routine, the insight that seeded Heptares She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through the company's acquisition by Sosei, helping establish structure-based drug design as a productive strategy β-adrenergic signaling set a career in motion 07:07 A venture capital visit to the LMB and the founding of Heptares As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery
